Key result
Food restriction or ACE inhibition restores preconditioning in mice, reducing infarct size and preserving LV contractility.
Why the study?
It is uncertain whether delayed preconditioning can effectively salvage myocardium in diabetes and metabolic syndrome and how to optimize this potential.
Does food restriction or ACE inhibition restore delayed preconditioning in diabetic and metabolic syndrome mouse models?
Does food restriction or ACE inhibition restore delayed preconditioning in diabetic and metabolic syndrome mouse models?
p-value: p=<0.05
Food restriction and ACE inhibition can restore the cardioprotective effects of delayed preconditioning in animal models of type II diabetes and metabolic syndrome.
May support testing food restriction or ACE inhibition to restore preconditioning in diabetic models; leaves open human translation.
BACKGROUND: Classical and delayed preconditioning are powerful endogenous protection mechanisms against ischemia-reperfusion damage. However, it is still uncertain whether delayed preconditioning can effectively salvage myocardium in patients with co-morbidities, such as diabetes and the metabolic syndrome. We investigated delayed preconditioning in mice models of type II diabetes and the metabolic syndrome and investigated interventions to optimize the preconditioning potential. METHODS: Hypoxic preconditioning was induced in C57Bl6-mice (WT), leptin deficient ob/ob (model for type II diabetes) and double knock-out (DKO) mice with combined leptin and LDL-receptor deficiency (model for metabolic syndrome). Twenty-four hours later, 30 min of regional ischemia was followed by 60 min reperfusion. Left ventricular contractility and infarct size were studied. The effect of 12 weeks food restriction or angiotensin-converting enzyme inhibition (ACE-I) on this was investigated. Differences between groups were analyzed for statistical significance by student's t-test or one-way ANOVA followed by a Fisher's LSD post hoc test. Factorial ANOVA was used to determine the interaction term between preconditioning and treatments, followed by a Fisher's LSD post hoc test. Two-way ANOVA was used to determine the relationship between infarct size and contractility (PRSW). A value of p<0.05 was considered significant. RESULTS: Left ventricular contractility is reduced in ob/ob compared with WT and even further reduced in DKO. ACE-I improved contractility in ob/ob and DKO mice. After ischemia/reperfusion without preconditioning, infarct size was larger in DKO and ob/ob versus WT. Hypoxic preconditioning induced a strong protection in WT and a partial protection in ob/ob mice. The preconditioning potential was lost in DKO. Twelve weeks of food restriction or ACE-I restored the preconditioning potential in DKO and improved it in ob/ob. CONCLUSION: Delayed preconditioning is restored by food restriction and ACE-I in case of type II diabetes and the metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Mieren et al. (2013) studied Type 2 diabetes and metabolic syndrome (myocardial ischemia-reperfusion injury) (n=188). Food restriction or ACE-inhibition (captopril) vs. Untreated mice was evaluated on Infarct size and left ventricular contractility (PRSW) after delayed preconditioning and ischemia-reperfusion (p=<0.05). Twelve weeks of food restriction or ACE-inhibition restored the delayed preconditioning potential in double knock-out mice and improved it in ob/ob mice, significantly reducing infarct size and preserving left ventricular contractility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: